DMII (Drugs Made In America Acquisition II) 1-Year Share Buyback Ratio: 0.00% (As of Mar. 2026 )


DMII Drugs Made In America Acquisition II Corp DMII
15 GF Score
Price $10.10
! 1 Warning Sign
View Full Analysis

What is Drugs Made In America Acquisition II 1-Year Share Buyback Ratio?

Drugs Made In America Acquisition II DMII 15 1-Year Share Buyback Ratio is 0.00 as of Mar. 2026. GuruFocus rates DMII with a GF Score™ of 15/100. The stock has 1 warning sign investors should review. Among 186 Diversified Financial Services companies, Drugs Made In America Acquisition II ranks worse than 537633.87% on this metric.

Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.

1-Year Share Buyback Ratio measures the proportion of a company's outstanding shares repurchased over the past year, calculated as the percentage change in shares outstanding from the previous year to the current year. A positive ratio may indicates share buybacks over the period, while a zero or negative ratio suggests no buybacks or potential share issuance. Drugs Made In America Acquisition II's current 1-Year Share Buyback Ratio was 0.00%.

DMII's 1-Year Share Buyback Ratio is not ranked *
in the Diversified Financial Services industry.
Industry Median: -10.9
* Ranked among companies with meaningful 1-Year Share Buyback Ratio only.

Drugs Made In America Acquisition II  (NAS:DMII) 1-Year Share Buyback Ratio Explanation

A positive ratio may indicates share buybacks over the period, while a zero or negative ratio suggests no buybacks or potential share issuance.

Be Aware

Investors usually like share buybacks. But as pointed by Warren Buffett, only if a company buys back shares at the prices below the stock's intrinsic value, it rewards remaining shareholders. If a company buys its overvalued stocks back, it destroys shareholder value.

Drugs Made In America Acquisition II 1-Year Share Buyback Ratio Related Terms

DMII vs BCSS, EVAC, CEPF: 1-Year Share Buyback Ratio Comparison

For the Shell Companies subindustry, Drugs Made In America Acquisition II's 1-Year Share Buyback Ratio, along with its competitors' market caps and 1-Year Share Buyback Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Drugs Made In America Acquisition II 1-Year Share Buyback Ratio vs Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, Drugs Made In America Acquisition II's 1-Year Share Buyback Ratio distribution charts can be found below:

* The bar in red indicates where Drugs Made In America Acquisition II's 1-Year Share Buyback Ratio falls into.


DMII
15GF Score
Drugs Made In America Acquisition II Corp DMII
1-Year Share Buyback Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Drugs Made In America Acquisition II 1-Year Share Buyback Ratio Calculation

Drugs Made In America Acquisition II's 1-Year Share Buyback Ratio for the quarter that ended in Mar. 2026 is calculated as

1-Year Share Buyback Ratio=(Shares Outstanding (EOP) (Mar. 2025 ) - Shares Outstanding (EOP) (Mar. 2026 )) / Shares Outstanding (EOP) (Mar. 2025 )
=(63.700 - 63.700) / 63.700
=0.0%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a 1-Year Share Buyback Ratio of 0.00 mean?
Drugs Made In America Acquisition II (DMII) has a 1-Year Share Buyback Ratio of 0.00 as of Mar. 2026. The 1-Year Share Buyback Ratio measures the proportion of a company's outstanding shares repurchased over the past year, calculated as the percentage change in shares outstanding from the previous year to the current year. View historical data for Drugs Made In America Acquisition II and its competitors. According to the industry distribution chart, Drugs Made In America Acquisition II ranks #999999 out of 186 companies in the Diversified Financial Services industry.
Is Drugs Made In America Acquisition II's 1-Year Share Buyback Ratio too high?
Drugs Made In America Acquisition II's current 1-Year Share Buyback Ratio is 0.00. Based on the distribution chart, Drugs Made In America Acquisition II ranks #999999 out of 186 companies in the Diversified Financial Services industry, which is in the bottom quartile relative to peers. Overall, Drugs Made In America Acquisition II has a GF Score™ of 15/100, reflecting its overall financial health beyond just this single metric.
How does Drugs Made In America Acquisition II's 1-Year Share Buyback Ratio compare to BCSS and EVAC?
According to the Diversified Financial Services industry distribution chart, Drugs Made In America Acquisition II ranks #999999 out of 186 companies for 1-Year Share Buyback Ratio. This places Drugs Made In America Acquisition II in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 1-Year Share Buyback Ratio for a Diversified Financial Services company?
A good 1-Year Share Buyback Ratio depends on the Diversified Financial Services industry context. However, 1-Year Share Buyback Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 1-Year Share Buyback Ratio mean?
A high 1-Year Share Buyback Ratio can signal that a stock is expensive relative to its fundamentals. The 1-Year Share Buyback Ratio measures the proportion of a company's outstanding shares repurchased over the past year, calculated as the percentage change in shares outstanding from the previous year to the current year. View historical data for Drugs Made In America Acquisition II and its competitors. Drugs Made In America Acquisition II's current 1-Year Share Buyback Ratio is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Drugs Made In America Acquisition II stock overvalued right now?
Drugs Made In America Acquisition II (DMII) has a current 1-Year Share Buyback Ratio of 0.00. The current 1-Year Share Buyback Ratio is 0.00. Drugs Made In America Acquisition II's overall GF Score™ is 15/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 1-Year Share Buyback Ratio calculated?
1-Year Share Buyback Ratio is calculated from a company's financial statements. For Drugs Made In America Acquisition II (DMII), the current 1-Year Share Buyback Ratio is 0.00 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Drugs Made In America Acquisition II Business Description

Address 420 Lexington Avenue, Suite 1402, New York, NY, USA, 10170
Drugs Made In America Acquisition II Corp is a blank check Company.
15GF Score

Get the complete analysis for DMII

1-Year Share Buyback Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$10.10
Price